4 May 2021
Hogan Lovells advises Labcorp on US$150m acquisition of Myriad Genetics’ Vectra testing business
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Michael Silver Lead | Hogan Lovells Cadwalader | Partner | M&A | New York |
| Allen Hicks Lead | Hogan Lovells Cadwalader | Partner | M&A | Washington D.C. |
| Matt Bowles | Hogan Lovells Cadwalader | Senior associate | Not stated | Not stated |
| Nick Eckstein | Hogan Lovells Cadwalader | Associate | Not stated | Not stated |
| Monica Pyles | Hogan Lovells Cadwalader | Associate | Not stated | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 150m (US$150 million)
- What the figure measures
- Total transaction value
- Client
- LabcorpBuy-side
- Counterparties
- Myriad Genetics (Sell-side)